In patients from TCGA, predominately collected from non-ICB-treated patients with ccRCC, PBRM1 mutations conferred a non-significant trend towards improved survival (Fig. 6f). The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.